Participants
thrombosis, fracture, tendinitis
THROMBOSIS, TENDINITIS
Participants were recruited through Starship Children’s Hospital (Auckland, NZ), Waikato Hospital (Hamilton, NZ), satellite schools, and word-of-mouth (i.e., self-referrals). Children aged 5 to 12 years 11 months with a diagnosis of any type of CP and level I-III on the GMFCS were recruited for the study. Additional inclusion criteria included the ability to understand and follow the instructions on the study protocol, ability to safely stand on a vibration plate with or without support, and having no planned surgery within 8 months before/after entering the study. The exclusion criteria included a bone fracture within 12 weeks of enrolment, history of using anabolic agents, glucocorticoids (excluding inhaled), or growth hormone therapy for at least 1 month within 3 months prior to enrolment, history of botulinum toxin injection into the lower limb(s) within 3 months before enrolment, and a history of an illness or findings on physical examination that might prevent a child from completing the study (e.g., acute thrombosis or tendinitis) [